Skip to main content

Icon Legend
Presentation Icons
Event Add-on
Event Add-on
In Person Only
In Person Only
Off-site Event
Off-site Event
Location: Marriott Marquis
Location: Marriott Marquis

  • Sunday, Sep 29th
    4:45 PM – 6:00 PM ET
    International 03 - Reirradiation in Clinical Practice: Navigating Current Evidence and Practical Solutions
    Location: Room 143
    Moderator: Tamer Refaat, MD, PhD, MS – Loyola University Chicago
    Moderator: Frank Giordano, MD – University Medical Center Mannheim
    InternationalPatient Reported Outcomes/Survivorship
     CE: 1.25
  • Monday, Sep 30th
    3:00 PM – 4:00 PM ET
    EDU 30 - Designing, Implementing and Interpreting Patient Reported Outcomes in Clinical Investigation
    Location: Room 140
    Moderator: Erin Gillespie, MD, MPH – University of Washington-Fred Hutchinson Cancer Center
    Patient Reported Outcomes/Survivorship
     CE: 1.00
  • Tuesday, Oct 1st
    8:00 AM – 9:00 AM ET
    EDU 35 - Improving Breast Cancer Related Lymphedema and Upper Extremity Dysfunction: Why Multidisciplinary Care Matters
    Location: Room 202
    Moderator: Leah Katz, MD – Columbia University College of Physicians and Surgeons
    Breast CancerPatient Reported Outcomes/Survivorship
     CE: 1.00
  • Tuesday, Oct 1st
    4:00 PM – 5:00 PM ET
    EDU 54 - Exercise after a Cancer Diagnosis: From Research to Real Life
    Location: Room 140
    Moderator: Randall Kimple, MD, PhD, MBA, FASTRO – Univ of Wisconsin
    Patient Reported Outcomes/Survivorship
     CE: 1.00
  • Tuesday, Oct 1st
    5:15 PM – 6:15 PM ET
    EDU 57 - Treatment De-Escalation Strategies for Locally Advanced Rectal Cancer
    Location: Room 150
    Moderator: Te Vuong, MD – McGill University
    Gastrointestinal CancerPatient Reported Outcomes/Survivorship
     CE: 1.00
  • Tuesday, Oct 1st
    5:15 PM – 6:15 PM ET
    EDU 58 - Sexuality after Cancer Therapy
    Location: Room 209
    Moderator: Peter Johnstone, MD, FASTRO – Moffitt Cancer Center
    Diversity, Equity and Inclusion in Health CarePatient Reported Outcomes/Survivorship
     CE: 1.00